News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,144 Results
Type
Article (86167)
Company Profile (649)
Press Release (753328)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232254)
Career Advice (4126)
Deals (39714)
Drug Delivery (126)
Drug Development (90808)
Employer Resources (198)
FDA (18014)
Job Trends (17334)
News (395627)
Policy (39681)
Tag
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (82)
Alliances (56679)
ALS (83)
Alzheimer's disease (1477)
Antibody-drug conjugate (ADC) (150)
Approvals (17991)
Artificial intelligence (234)
Autoimmune disease (28)
Automation (12)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (447)
Bladder cancer (77)
Brain cancer (26)
Breast cancer (239)
Cancer (2101)
Cardiovascular disease (147)
Career advice (3533)
Career pathing (34)
CAR-T (165)
Cell therapy (461)
Cervical cancer (18)
Clinical research (72934)
Collaboration (812)
Company closure (2)
Compensation (475)
Complete response letters (28)
COVID-19 (2834)
CRISPR (46)
C-suite (233)
Cystic fibrosis (100)
Data (1967)
Decentralized trials (2)
Denatured (46)
Depression (40)
Diabetes (193)
Diagnostics (6768)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (118)
Drug pricing (98)
Drug shortages (17)
Duchenne muscular dystrophy (85)
Earnings (95711)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (128813)
Executive appointments (631)
FDA (19061)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (664)
Gene editing (106)
Generative AI (22)
Gene therapy (335)
GLP-1 (740)
Government (5120)
Grass and pollen (4)
Guidances (114)
Healthcare (20744)
Huntington's disease (26)
IgA nephropathy (29)
Immunology and inflammation (135)
Indications (25)
Infectious disease (2952)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (87)
Interviews (813)
IPO (17704)
IRA (38)
Job creations (5189)
Job search strategy (2861)
Kidney cancer (11)
Labor market (46)
Layoffs (554)
Leadership (22)
Legal (10057)
Liver cancer (73)
Lung cancer (308)
Lymphoma (140)
Machine learning (7)
Management (65)
Manufacturing (309)
MASH (76)
Medical device (14302)
Medtech (14307)
Mergers & acquisitions (22292)
Metabolic disorders (614)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (104)
Neuropsychiatric disorders (23)
Neuroscience (1991)
NextGen: Class of 2025 (7666)
Non-profit (5058)
Now hiring (41)
Obesity (325)
Opinion (271)
Ovarian cancer (72)
Pain (74)
Pancreatic cancer (67)
Parkinson's disease (136)
Partnered (19)
Patents (202)
Patient recruitment (99)
Peanut (48)
People (64952)
Pharmaceutical (131)
Pharmacy benefit managers (14)
Phase I (22541)
Phase II (31723)
Phase III (23825)
Pipeline (1179)
Policy (150)
Postmarket research (3542)
Preclinical (10175)
Press Release (72)
Prostate cancer (91)
Psychedelics (34)
Radiopharmaceuticals (251)
Rare diseases (366)
Real estate (7384)
Recruiting (75)
Regulatory (26486)
Reports (56)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (34)
Schizophrenia (72)
Series A (127)
Series B (75)
Service/supplier (25)
Sickle cell disease (47)
Special edition (20)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4288)
State (2)
Stomach cancer (11)
Supply chain (51)
Tariffs (44)
The Weekly (83)
Vaccines (745)
Venture capitalists (42)
Weight loss (229)
Women's health (37)
Worklife (20)
Date
Last 7 days (783)
Last 30 days (2484)
Last 365 days (28255)
2025 (9768)
2024 (34054)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (55)
Alaska (6)
Arizona (247)
Arkansas (8)
Asia (49896)
Australia (8803)
California (5584)
Canada (1623)
China (512)
Colorado (171)
Connecticut (221)
Delaware (139)
Europe (114243)
Florida (700)
Georgia (152)
Hawaii (1)
Idaho (64)
Illinois (452)
India (25)
Indiana (277)
Iowa (10)
Japan (144)
Kansas (113)
Kentucky (16)
Louisiana (9)
Maine (58)
Maryland (865)
Massachusetts (4378)
Michigan (187)
Minnesota (318)
Mississippi (1)
Missouri (53)
Montana (24)
Nebraska (26)
Nevada (58)
New Hampshire (50)
New Jersey (1581)
New Mexico (27)
New York (1563)
North Carolina (1027)
North Dakota (8)
Northern California (2459)
Ohio (167)
Oklahoma (13)
Oregon (45)
Pennsylvania (1169)
Puerto Rico (13)
Rhode Island (25)
South America (1649)
South Carolina (5)
South Dakota (1)
Southern California (2097)
Tennessee (30)
Texas (758)
United States (20764)
Utah (119)
Virginia (106)
Washington D.C. (41)
Washington State (526)
West Virginia (1)
Wisconsin (43)
840,144 Results for "rejuvenate bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy
July 1, 2024
·
4 min read
Press Releases
Shift Bioscience Announces Key Appointments to Advance Rejuvenation Therapeutics Pipeline
March 12, 2025
·
3 min read
Biotech Beach
Rejuvenate Bio to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Rejuvenate Bio today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually.
April 22, 2024
·
2 min read
Biotech Beach
Rejuvenate Bio Announces Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in the Journal Cellular Reprogramming
Rejuvenate Bio today announced publication of groundbreaking research in the peer-reviewed journal Cellular Reprogramming.
February 22, 2024
·
3 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis
Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs’ mobility and overall quality of life.
February 14, 2024
·
2 min read
Press Releases
clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors
October 9, 2024
·
3 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Drug Development
Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways.
October 9, 2023
·
4 min read
Press Releases
ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells
July 12, 2024
·
2 min read
1 of 84,015
Next
